Tracking coronary calcification and atherosclerotic lesions in patients with stable angina pectoris undergoing nifedipine therapy

Michael Motro, Bridget Anne Kirwan, Sophie De Brouwer, Philip A. Poole-Wilson, Joseph Shemesh

Research output: Contribution to journalArticlepeer-review

Abstract

Aims: The objective of the Coronary Calcification (CC) study was to determine in patients with chronic symptomatic coronary artery disease, if, in addition to standard therapy, nifedipine GITS, relative to placebo, would arrest or slow down the progression of calcium or the development of new atherosclerotic lesions in the coronary arteries. Methods and Results: The CC study was part of the ACTION trial. Multi-slice computerized tomography was used to measure and track the progression of CC. Five hundred and eighteen patients were included in this study. The changes in calcium score from baseline every 24 months, over a period of between 4.5 and 6 years, were similar in the nifedipine and placebotreatment groups (p = 0.8). Compared to placebo, more patients in the nifedipine group (71 vs. 60%) were free of new calcified atherosclerotic lesions during follow-up(p = 0.095). Conclusion: Nifedipine GITS was not effective in slowing down the progression of calcium in advanced atherosclerotic plaques in patients with stable angina pectoris. Although statistically not significant, Nifedipine demonstrated a trend in slowing down the development of new atherosclerotic lesions.

Original languageEnglish
Pages (from-to)165-171
Number of pages7
JournalCardiology
Volume107
Issue number3
DOIs
StatePublished - Mar 2007

Keywords

  • Atherosclerotic lesions
  • Coronary calcification
  • Nifedipine GITS

Fingerprint

Dive into the research topics of 'Tracking coronary calcification and atherosclerotic lesions in patients with stable angina pectoris undergoing nifedipine therapy'. Together they form a unique fingerprint.

Cite this